Endocrinology, Vol 121, 1454-1460, Copyright © 1987 by Endocrine Society

ARTICLES

A new cytotoxin specific for the target cells of corticotropin- releasing factor

J Schwartz, B Penke, J Rivier and W Vale
Clayton Foundation Laboratories for Peptide Biology, Salk Institute, La Jolla, California 92037.

To develop a cytotoxic agent selective for pituitary corticotropes, an analog of CRF, [Nle21,38,Arg36]rat (r) CRF, was conjugated to the plant toxin gelonin using glutaraldehyde as a cross-linking agent. In a two- step synthesis, glutaraldehyde was first coupled to the amino-terminal of the CRF analog. This was then reacted with gelonin to form a product, which contained 20 mol [Nle21,38,Arg36]rCRF/mol gelonin, as indicated by amino acid analysis. Efficacy and specificity of the gelonin-[Nle21,38,Arg36]rCRF conjugate were assessed in cultured rat anterior pituitary cells 3 days after a 12-h exposure to the cytotoxic conjugate, CRF, or gelonin. While pretreatment with the cytotoxic gelonin-[Nle21,38,Arg36]rCRF conjugate decreased cellular ACTH content by 74%, pretreatment with appropriate concentrations of CRF had no significant effect on cellular ACTH content. The ACTH secretory response to 2.5 nM CRF was completely eliminated by pretreatment with the gelonin-[Nle21,38,Arg36]rCRF conjugate; in contrast, pretreatment with identical doses of CRF had minimal effect. Neither pretreatment with CRF nor pretreatment with the gelonin-[Nle21,38,Arg36] rCRF conjugate had any effect on the content of LH or the LH secretory response to GnRH. These results indicate the efficacy and specificity of the conjugate of [Nle21,38,Arg36]rCRF to gelonin in eliminating CRF target cells.

This article has been cited by other articles:

				K. Farrand, I. C. McMillen, S. Tanaka, and J. Schwartz Subpopulations of Corticotrophs in the Sheep Pituitary during Late Gestation: Effects of Development and Placental Restriction Endocrinology, October 1, 2006; 147(10): 4762 - 4771. [Abstract] [Full Text] [PDF]

				G S Harrison, M E Wierman, T M Nett, and L M Glode Gonadotropin-releasing hormone and its receptor in normal and malignant cells Endocr. Relat. Cancer, December 1, 2004; 11(4): 725 - 748. [Abstract] [Full Text] [PDF]

				D. Maciejewski-Lenoir, S. C. Heinrichs, X.-J. Liu, N. Ling, A. Tucker, Q. Xie, D. A. Lappi, and D. E. Grigoriadis Selective Impairment of Corticotropin-Releasing Factor1 (CRF1) Receptor-Mediated Function Using CRF Coupled to Saporin Endocrinology, February 1, 2000; 141(2): 498 - 504. [Abstract] [Full Text] [PDF]